AzTrials
AzTrials

Chronic Obstructive Pulmonary DiseaseNCT02140892

A Comparison Study of Two Respiratory Physical Therapy Methods and Standard Medical Treatment for Treating COPD Patients During Acute Exacerbation

A study testing respiratory physical therapy manual technique- Autogenic Drainage and respiratory physical therapy technique- IPV in people with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis, run by Sheba Medical Center.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

One of the main goals of the respiratory physical therapy is to help people who are suffering from accumulating of secretions in their airways and lungs. Chronic Obstructive Pulmonary Disease (COPD) patients are often hospitalized with an Acute Exacerbation of their medical condition. Read more about this study

Who is it for?
Ages 50 to 80 years
What is being tested?
respiratory physical therapy manual technique- Autogenic Drainage and respiratory physical therapy technique- IPV
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
No sites listed yet
Study dates
Jul 2014to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • clinical diagnosis of Acute Exacerbation of COPD or Acute Exacerbation of Chronic Bronchitis
  • Respiratory Rate>25
  • PaCO2> 45 mmHg
  • 7.35 < PH < 7.38

Who cannot join

  • intubation
  • apnea
  • glasgow coma scale < 8
  • pneumothorax
  • FEV1 < 50% predicted
  • Ischemic Hearth Disease

Trial locations and contacts

No sites are listed yet.

Yaakov (kobi) Dagan, Msc. contact

0523694979

kobi.dagan@sheba.health.gov.il

About this study

One of the main goals of the respiratory physical therapy is to help people who are suffering from accumulating of secretions in their airways and lungs.

Chronic Obstructive Pulmonary Disease (COPD) patients are often hospitalized with an Acute Exacerbation of their medical condition.

Read more

Those patients usually get only the standard medical care during the acute phase and don't get respiratory physical therapy treatment.

The study's main aim is to investigate if respiratory physical therapy treatment in addition to standard medical care during the acute phase, can improve the respiratory and medical condition and reduce hospitalization stay.

In order to do so we will compare three groups of COPD patients during acute exacerbation; two groups will get one out of two respiratory physical therapy techniques; manually or Intrapulmonary Percussive Ventilator (IPV) in addition to standard medical care and the third group will get standard medical care alone.

Being tested
respiratory physical therapy manual technique- Autogenic Drainage, respiratory physical therapy technique- IPV
Medical subject headings
Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • respiratory physical therapy manual technique- Autogenic DrainageProcedure or surgery

  • respiratory physical therapy technique- IPVDevice

Study groups in NCT02140892
Study groupRoleWhat they receive
respiratory physical therapy manual techniqueExperimentalrespiratory physical therapy manual technique- Autogenic Drainage
Receives: Procedure: respiratory physical therapy manual technique- Autogenic Drainage
respiratory physical therapy technique- IPVExperimentalrespiratory physical therapy technique- Intrapulmonary Percussive Ventilation
Receives: Device: respiratory physical therapy technique- IPV
standart medical careNo interventionstandard medical care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. length of stay in the hospital

    Measured: up to three months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2014 (estimated)
  2. Study startJul 2014
  3. Primary completionJul 2015 (estimated)
  4. Study completionDec 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02140892
Sponsor's protocol ID
SHEBA-13-0697-YO-CTIL
Status last verified
May 2014
First submitted
14 May 2014
Last updated
16 May 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing respiratory physical therapy manual technique- Autogenic Drainage and respiratory physical therapy technique- IPV in people with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis, run by Sheba Medical Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 May 2014. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Yaakov (kobi) Dagan, Msc. (0523694979, kobi.dagan@sheba.health.gov.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

length of stay in the hospital (time frame: up to three months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2014.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02140892 | AzTrials